You are here

Eli Lilly

AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

Pharmaceutical Business Review

Tue, 02/11/25 - 11:27 am

radiopharmaceuticals

alpha radiation

Wegovy and Ozempic stars dim amid overuse concerns

Axios

Tue, 02/11/25 - 11:17 am

South Korean Biotech Firm Olix Exports MASH Treatment to Eli Lilly for 910 Billion Won

Business Korea

Mon, 02/10/25 - 10:24 pm

Olix Pharmaceuticals

Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease

Clinical Trials Arena

Mon, 02/10/25 - 10:17 am

Crohn's Disease

clinical trials

Eli Lilly’s earnings, shares lifted by obesity drug sales

BioPharma Dive

Thu, 02/6/25 - 10:40 pm

Lilly’s investigational Alzheimer’s to be investigated in prevention trial

Clinical Trials Arena

Wed, 02/5/25 - 11:14 am

clinical trials

Alzheimer's disease

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Forbes

Fri, 01/31/25 - 10:59 am

New Zepbound TV Commercial Inspires ‘Change’

Xtalks

Wed, 01/29/25 - 07:25 pm

DTC advertising

Eli Lilly trial update on kidney drug hurts Tectonic

MSN/Seeking Alpha

Tue, 01/28/25 - 09:39 pm

Tectonic Therapeutics

clinical trials

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Motley Fool

Sun, 01/26/25 - 04:13 pm

Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

Fierce Pharma

Tue, 01/21/25 - 07:13 pm

Alzheimer's disease

Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy

Fierce Pharma

Fri, 01/17/25 - 11:34 am

clinical trials

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

BioPharma Dive

Fri, 01/17/25 - 11:30 am

Lilly's Omvoh scores second IBD win with FDA nod in Crohn's

First Word Pharma

Wed, 01/15/25 - 11:50 pm

Crohn's Disease

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

CNBC

Tue, 01/14/25 - 11:07 am

Lilly pads cancer drug pipeline with Scorpion deal

BioPharma Dive

Mon, 01/13/25 - 11:00 am

Scorpion Therapeutics

5 questions facing pharma in 2025

BioPharma Dive

Fri, 01/10/25 - 11:47 am

Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect

Fierce Biotech

Fri, 01/10/25 - 11:39 am

idiopathic pulmonary fibrosis

Mediar Therapeutics

Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033

Clinical Trials Arena

Fri, 01/10/25 - 11:18 am

Alzheimer's disease

Lilly crafts deal for up to 5 new ALS antibodies with UK biotech Alchemab

Fierce Biotech

Thu, 01/9/25 - 11:18 am

Alchemab Therapeutics

Pages